Vitamin D3 Levels in COVID-19 Outpatients From Western Mexico
NCT ID: NCT04793243
Last Updated: 2021-03-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
42 participants
INTERVENTIONAL
2020-08-17
2020-10-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vitamine D3 Supplementation in Patients With Serum Values +/- 20ng/ml
NCT04810949
Efficacy of Vitamin D Supplementation to Prevent the Risk of Acquiring COVID-19 in Healthcare Workers
NCT04535791
Vitamin D on Prevention and Treatment of COVID-19
NCT04334005
Vitamin D Supplementation and Clinical Improvement in COVID-19
NCT05126602
Effectiveness and Safety of Two Vitamin D3 Supplementation Regimens in Adults with Early-stage COVID-19
NCT06585995
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
Formed by 22 patients that received oral supplementation of 10,000 IU daily for fourteen days of vitamin D3
Vitamin D3
Patients received oral supplementation of 10,000 IU daily for fourteen days of vitamin D3
Control group
Formed by 20 patients that did not receive supplementation
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vitamin D3
Patients received oral supplementation of 10,000 IU daily for fourteen days of vitamin D3
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Control group: Patients with positive PCR for COVID-19 of both sexes
* Both groups: Mexican individuals, after signing the informed consent letter and over 18 years of age.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Guadalajara
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jose Francisco Munoz Valle
Provost of the University Center of Health Sciences
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
José F Muñoz-Valle, Dr.
Role: PRINCIPAL_INVESTIGATOR
University of Guadalajara
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universidad de Guadalajara
Guadalajara, Jalisco, Mexico
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CI-07620
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.